Cargando…
Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3
Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of chemotherapeutic treatment failure in CRC. Therefore, extracting the bioactive compounds from natural products with anti-carcino...
Autores principales: | Fu, Rong, Yang, Peng, Li, Zongwei, Liu, Wen, Amin, Sajid, Li, Zhuoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685981/ https://www.ncbi.nlm.nih.gov/pubmed/31391454 http://dx.doi.org/10.1038/s41419-019-1825-5 |
Ejemplares similares
-
Avenanthramides as lipoxygenase inhibitors
por: Landberg, Rikard, et al.
Publicado: (2020) -
The Biosynthetic Pathway of Major Avenanthramides in Oat
por: Li, Zhiyong, et al.
Publicado: (2019) -
Avenanthramides attenuate inflammation and atrophy in muscle cells
por: Yeo, Dongwook, et al.
Publicado: (2019) -
The Adapted POM Analysis of Avenanthramides In Silico
por: Maliar, Tibor, et al.
Publicado: (2023) -
Synthesis of avenanthramides using engineered Escherichia coli
por: Lee, Su Jin, et al.
Publicado: (2018)